Old West Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Old West Investment Management’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-70,101	Closed	-$14K	–	90
2018 Q1	$14K	Sell	70,101 -7,153	-9%	-$6.59K	0.01%	81
2017 Q4	$99K	Sell	77,254 -78,048	-50%	-$127K	0.06%	70
2017 Q3	$329K	Sell	155,302 -26,572	-15%	-$64.8K	0.17%	60
2017 Q2	$527K	Sell	181,874 -24,813	-12%	-$74.4K	0.28%	52
2017 Q1	$711K	Buy	206,687 +669	+0.3%	+$2.64K	0.38%	45
2016 Q4	$358K	Buy	+206,018	New	+$484K	0.22%	46

Other funds holding OREX

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Old West Investment Management's OREX Position: Q2 2018 in Review

Old West Investment Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 70,101 shares — an estimated $14K sold.

Old West Investment Management first reported a position in OREX in Q4 2016 and held it in 6 quarters. The position peaked at $711K in Q1 2017. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

Old West Investment Management reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Old West Investment Management sold 70,101 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $14K.
Old West Investment Management first reported a position in Orexigen Therapeutics, Inc. in Q4 2016 and held it in 6 quarters.
Old West Investment Management's Orexigen Therapeutics, Inc. position peaked at $711K in Q1 2017.
4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Old West Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.